Original Source(s)
Related Content
FDA Approves Baxdrostat for Resistant Hypertension
Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.
May 18, 2026
-
2 min
AD Not Linked to Early CV Risk Markers
Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.
May 27, 2026
-
5 min
Combination Therapy Shows Potential in Psoriasis, Obesity
Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.
May 20, 2026
-
5 min